Obamacare’s Brand Drug Tax Would Be Repealed Under GOP’s ‘Replace’ Proposal
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry hasn’t publicly opposed the tax, which it negotiated as part of the creation of the Affordable Care Act.
You may also be interested in...
Is This The Year R&D Tax Credits Become Permanent?
Senate Finance Committee Chairman Hatch’s top priority for the year is to develop legislation reforming the tax code. He forms five bipartisan committee working groups to develop and submit legislative recommendations by May.
$8 Billion And Counting: Pharma Paying Its ACA Taxes
HHS OIG report shows pharma industry fee is being paid, albeit with a few bumps along the way.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.